BioNTech to Disburse $1.3 Billion in COVID Vaccine Royalties to the U.S. and UPenn

BioNTech announced on Friday that it has reached two distinct settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania regarding the payment of royalties associated with its COVID-19 vaccine.



Source link